183 related articles for article (PubMed ID: 38179307)
1. SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis.
Meregildo-Rodriguez ED; Asmat-Rubio MG; Vásquez-Tirado GA
Front Endocrinol (Lausanne); 2023; 14():1307715. PubMed ID: 38179307
[TBL] [Abstract][Full Text] [Related]
2. Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.
Pranata R; Tondas AE; Vania R; Toruan MPL; Lukito AA; Siswanto BB
Catheter Cardiovasc Interv; 2020 Nov; 96(6):1200-1212. PubMed ID: 31912996
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.
Liang M; Yang S; Fu N
Medicine (Baltimore); 2017 Jul; 96(27):e7384. PubMed ID: 28682890
[TBL] [Abstract][Full Text] [Related]
4. Effect of Nicorandil Administration on Preventing Contrast-Induced Nephropathy: A Meta-Analysis.
Zhan B; Huang X; Jiang L; Bao H; Cheng X
Angiology; 2018 Aug; 69(7):568-573. PubMed ID: 28950711
[TBL] [Abstract][Full Text] [Related]
5. Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.
Kanbay M; Siriopol D; Ozdogan E; Afsar B; Ertuglu LA; Grigore M; Sag AA; Kuwabara M; Lanaspa MA; Ortiz A; Johnson RJ; Covic A
Int Urol Nephrol; 2020 Mar; 52(3):541-547. PubMed ID: 32008199
[TBL] [Abstract][Full Text] [Related]
6. Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: an umbrella review on meta-analyses.
Mahapatro A; Nobakht S; Mukesh S; Daryagasht AA; Korsapati AR; Jain SM; Soltani Moghadam S; Moosavi R; Javid M; Hassanipour S; Prabhu SV; Keivanlou MH; Amini-Salehi E; Nayak SS
Eur J Med Res; 2024 Apr; 29(1):210. PubMed ID: 38561791
[TBL] [Abstract][Full Text] [Related]
7. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
[TBL] [Abstract][Full Text] [Related]
8. Nicorandil Reduces the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography/Intervention - Systematic Review and Meta-Analysis of Randomized Controlled Trials Including GRADE Qualification.
Pranata R; Vania R; Alkatiri AA; Firman D; Lukito AA
Cardiovasc Revasc Med; 2020 Sep; 21(9):1121-1127. PubMed ID: 31959562
[TBL] [Abstract][Full Text] [Related]
9. The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction.
Özkan U; Gürdoğan M
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984506
[No Abstract] [Full Text] [Related]
10. Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials.
Wei XB; Jiang L; Liu XR; Yu DQ; Tan N; Chen JY; Zhou YL; He PC; Liu YH
Eur J Clin Pharmacol; 2016 Nov; 72(11):1311-1318. PubMed ID: 27695914
[TBL] [Abstract][Full Text] [Related]
11. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Fasting Blood Glucose Levels and the Risk of Contrast-Induced Nephropathy in Patients With Diabetes and Pre-diabetes Undergoing Coronary Arteriography or Percutaneous Coronary Intervention: A Cross-Sectional Study.
Zhang P; Fu H; Liu J; Liu X; Yang S; Guo Z; Fu N
Angiology; 2022 Aug; 73(7):660-667. PubMed ID: 35084237
[TBL] [Abstract][Full Text] [Related]
13. The effect of trimetazidine on contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention - A systematic review and meta-analysis.
Martha JW; Pranata R; Wibowo A; Irvan I; Afrianti R; Akbar MR
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):3045-3053. PubMed ID: 33877668
[TBL] [Abstract][Full Text] [Related]
14. Remote Ischemic Preconditioning Reduces the Risk of Contrast-Induced Nephropathy in Patients with Moderate Renal Impairment Undergoing Percutaneous Coronary Angiography: A Meta-Analysis.
Deng J; Lu Y; Ou J; Shao X; Wang X; Xie H
Kidney Blood Press Res; 2020; 45(4):549-564. PubMed ID: 32688358
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic atorvastatin prior to intra-arterial administration of iodinated contrast media for prevention of contrast-induced acute kidney injury: A meta-analysis of randomized trial data
.
Sun YY; Liu LY; Sun T; Wu MY; Ma FZ
Clin Nephrol; 2019 Sep; 92(3):123-130. PubMed ID: 31347493
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide as a biomarker for predicting contrast-induced nephropathy in patients undergoing coronary angiography/intervention: A systematic review and meta-analysis.
Wu X; Yang X; Xu Z; Li J
Medicine (Baltimore); 2022 Dec; 101(52):e32432. PubMed ID: 36595981
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis.
He H; Chen XR; Chen YQ; Niu TS; Liao YM
J Interv Cardiol; 2019; 2019():2750173. PubMed ID: 31772520
[TBL] [Abstract][Full Text] [Related]
18. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
[TBL] [Abstract][Full Text] [Related]
19. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Liu Y; Hong D; Wang AY; Guo R; Smyth B; Liu J; Sun G; Chen S; Tan N; Jardine M; Brieger D; Shaman A; Islam S; Chen J; Gallagher M
BMC Cardiovasc Disord; 2019 Apr; 19(1):87. PubMed ID: 30961544
[TBL] [Abstract][Full Text] [Related]
20. Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention.
Zhang H; Fu H; Fu X; Zhang J; Zhang P; Yang S; Zeng Z; Fu N; Guo Z
BMC Nephrol; 2021 Jun; 22(1):206. PubMed ID: 34078303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
